ATE101198T1 - Verfahren zur herstellung von produkten von fremdgenen. - Google Patents

Verfahren zur herstellung von produkten von fremdgenen.

Info

Publication number
ATE101198T1
ATE101198T1 AT88118584T AT88118584T ATE101198T1 AT E101198 T1 ATE101198 T1 AT E101198T1 AT 88118584 T AT88118584 T AT 88118584T AT 88118584 T AT88118584 T AT 88118584T AT E101198 T1 ATE101198 T1 AT E101198T1
Authority
AT
Austria
Prior art keywords
ltr
downstream
foreign gene
processes
foreign genes
Prior art date
Application number
AT88118584T
Other languages
English (en)
Inventor
Toshiya Takano
Minoru S H Ko
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE101198T1 publication Critical patent/ATE101198T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88118584T 1987-11-09 1988-11-08 Verfahren zur herstellung von produkten von fremdgenen. ATE101198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28289387 1987-11-09
EP88118584A EP0316717B1 (de) 1987-11-09 1988-11-08 Verfahren zur Herstellung von Produkten von Fremdgenen

Publications (1)

Publication Number Publication Date
ATE101198T1 true ATE101198T1 (de) 1994-02-15

Family

ID=17658465

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88118584T ATE101198T1 (de) 1987-11-09 1988-11-08 Verfahren zur herstellung von produkten von fremdgenen.

Country Status (6)

Country Link
US (2) US5646013A (de)
EP (1) EP0316717B1 (de)
AT (1) ATE101198T1 (de)
CA (1) CA1309044C (de)
DE (1) DE3887635T2 (de)
ES (1) ES2061604T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02500161A (ja) * 1986-08-01 1990-01-25 ジェネテイックス・インスティテュート・インコーポレイテッド 異種遺伝子の高水準誘導発現
EP0495465A3 (en) * 1991-01-15 1992-12-16 Coulston International Corporation Immuno-enzymatic test for the detection of viral antibody
US5665873A (en) * 1995-02-09 1997-09-09 Dana Farber Cancer Institute Glucocorticoid response elements
FR2782732A1 (fr) * 1998-08-28 2000-03-03 Transgene Sa Systeme d'expression inductible
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
CA2524619A1 (en) * 2005-11-22 2007-05-22 Ottawa Health Research Institute Novel stem cells, nucleotide sequences and proteins therefrom

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
US4374927A (en) * 1981-02-24 1983-02-22 The Board Of Trustees Of The Leland Stanford Jr. University Extrachromosomal regulation of expression
EP0105141A3 (de) * 1982-09-09 1985-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Rekombinante DNS Moleküle, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Hepatitis B Oberflächen-Antigen (HBsAg) und pharmazeutische Zusammensetzungen die das HBsAg enthalten
JPH0630590B2 (ja) * 1985-08-30 1994-04-27 株式会社ヤクルト本社 複合プラスミドベクタ−
EP0213628A3 (de) * 1985-09-03 1988-09-21 Yeda Research And Development Company, Ltd. Expression von Superoxiddismutase in eukaryotischen Zellen
JPH02500161A (ja) * 1986-08-01 1990-01-25 ジェネテイックス・インスティテュート・インコーポレイテッド 異種遺伝子の高水準誘導発現
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays

Also Published As

Publication number Publication date
CA1309044C (en) 1992-10-20
DE3887635D1 (de) 1994-03-17
EP0316717A1 (de) 1989-05-24
ES2061604T3 (es) 1994-12-16
EP0316717B1 (de) 1994-02-02
DE3887635T2 (de) 1994-06-01
US5646013A (en) 1997-07-08
US5534419A (en) 1996-07-09

Similar Documents

Publication Publication Date Title
ATE323169T1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
FI880899A0 (fi) Oleellisesti puhdas DNA ja RNA ja menetelmä erytropoietiinin ekspressoimiseksi
DE3881152D1 (de) Auslieferungssysteme zur geschmacks- und suessigkeitserhoehung und verfahren zur herstellung derselben.
DE3886184D1 (de) Vorrichtung zur lagerung und kontrollierten abgabe von unter druck stehenden produkten und verfahren zu ihrer herstellung.
PT87083A (pt) Vascular-antikoaquilierende proteine dna die diese kodieren verfahren zu deren herstellung sowie deren verwendung
ATE123520T1 (de) Kex2-endoprotease und verfahren zu ihrer herstellung.
DE3684376D1 (de) Hohlfasermembran fuer kuenstliche lunge, verfahren zu ihrer herstellung und diese hohlfasermembran verwendende kuenstliche lunge.
NO970049L (no) Nukleinsyre holdt i preparat, dets fremstilling og anvendelse
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
MA21169A1 (fr) Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant.
DE3867364D1 (de) Stabilisiertes kaugummiprodukt und verfahren zu dessen herstellung.
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE3881478D1 (de) Substituierte carbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende fungizide fuer acker- und gartenbau.
DE68914672D1 (de) Verfahren zur herstellung von methacrylsäure und methacrolein.
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ATE101198T1 (de) Verfahren zur herstellung von produkten von fremdgenen.
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
NO174032C (no) Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel
WO1999047678A3 (en) Interferon alpha plasmids and delivery systems, and methods of making and using the same
DE3860864D1 (de) Optisch aktive alpha-aminoaldehyde, verfahren zu ihrer herstellung und ihre verwendung zur stereoselektiven herstellung optisch aktiver beta-aminoalkohole.
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
DE3576523D1 (de) Rekombinante dna enthaltende coryneformbakterien und verfahren zur herstellung von aromatischen aminosaeuren unter verwendung dieser bakterien.
DE3888443D1 (de) Verfahren zur Herstellung von Dihydrochinacridonen, Chinacridonen und Chinacridonchinonen.
DE3871410D1 (de) (phenylethenyl)phenylpropionaldehyd und verfahren zur herstellung von (benzoylphenyl)propionsaeure unter verwendung dieser verbindung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time